Moderna, Merck Shares Fall After Possible Melanoma Data Leak
FROM THE WIRE · FINANCE.YAHOO.COM
(Bloomberg) -- Shares of Moderna Inc. and Merck & Co. fell after reports emerged about the results of the companies' widely anticipated personalized melanoma vaccine, suggesting a possible leak of the data that's slated to be released this weekend. Most Read from Bloomberg…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA possible leak of melanoma vaccine data is weighing on the shares of both companies.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna shares plunged as much as 25% on Thursday.
- 02Merck shares dropped 3.9%.
- 03Results of the personalized melanoma vaccine are slated for release this weekend.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Moderna, Inc.191.99 USD+2.85%today -21.89%Negative Merck & Co., Inc.149.49 USD+1.12%today -0.26%Negative
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets